Skip to main content

Table 1 Main demographic, biochemical, and clinical characteristics of the study population

From: Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients

Total N = 174

Diabetics (n = 86)

Non-diabetics (n = 88)

p Value

Age

64.1 ± 6.8

64.3 ± 8.6

0.84

Male n (%)

73 (84.9)

76 (86.3)

0.83

Hypertension

64 (80)

74 (84.1)

0.54

Smokers

7 (8.8)

7 (8.6)

 

Previous smokers

38 (48.1)

33 (40.7)

0.6

Non-smokers

34 (43.0)

41 (50.6)

 

Previous AMI

36 (46.1)

17 (22.7)

0.004

CABG

28 (34.6)

23 (26.1)

0.25

PCI

24 (30.4)

28 (32.2)

0.87

EF

0.61 ± 0.06

0.62 ± 0.06

0.2

Tri-vessel disease

38 (52)

43 (51.2)

1.0

Bi-vessel disease

35 (48)

41 (48.8)

1.0

LAD disease

63 (87.5)

74 (86.0)

1.0

Collateral circulation

34 (50.7)

38 (46.9)

0.64

Collateral grade 2/3

30 (88.2)

32 (84.2)

0.74

Weight (kg)

74.5 ± 11.0

73.2 ± 12.7

0.51

Height (m)

1.66 ± 8.1

1.66 ± 9.1

0.75

BMI

26.5 ± 2.8

26.4 ± 3.2

0.54

Fasting glycemia

143.5 ± 47.0

99.0 ± 9.4

0.0001

A1C

7.35 ± 1.61

5.63 ± 0.30

0.0001

BUN

41.9 ± 13.4

40.1 ± 9.4

0.32

Creatinine

1.04 ± 0.23

1.07 ± 0.20

0.37

Total cholesterol

156.5 ± 34.5

168.9 ± 36.3

0.02

LDL cholesterol

90.5 ± 27.4

102.0 ± 32.7

0.01

HDL cholesterol

38.0 ± 9.6

40.3 ± 9.0

0.12

Triglycerides

147.2 ± 88.3

132.6 ± 72.3

0.24

  1. Data are expressed as means ± standard deviation or as absolute and relative risks
  2. AMI stands for acute myocardial infarction, CABG coronary artery bypass surgery, PCI percutaneous coronary intervention, EF ejection fraction, LAD left anterior descending, BMI body mass index, A1C glycosylated hemoglobin, BUN blood urea nitrogen, LDL low-density lipoprotein, HDL high-density lipoprotein